Literature DB >> 3717494

Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study.

A L Katzenstein, J L Myers, W D Prophet, L S Corley, M S Shin.   

Abstract

The clinical, radiographic, and pathologic features were studied in 24 cases of bronchiolitis obliterans and 16 cases of usual interstitial pneumonia, to define better their distinguishing characteristics. Bronchiolitis obliterans had a more acute onset often associated with fever, while the presentation of usual interstitial pneumonia was insidious with dyspnea and cough. The radiographs in usual interstitial pneumonia uniformly showed bilateral interstitial opacities, while they were more variable in bronchiolitis obliterans, with air space densities in 15 and interstitial opacities in nine. Prognosis was considerably better for bronchiolitis obliterans patients. Resolution of disease occurred in nearly half, while no patient with usual interstitial pneumonia recovered. Three individuals with bronchiolitis obliterans (12.5%) died of progressive disease, compared to 10 with usual interstitial pneumonia (62.5%). Pathologically, the lesion in bronchiolitis obliterans affected mainly air spaces in a peribronchiolar distribution, while the changes in usual interstitial pneumonia were mainly interstitial and randomly distributed. The fibrosis in bronchiolitis obliterans was composed of proliferating fibroblasts, compared to collagen deposition in usual interstitial pneumonia. These findings emphasize that bronchiolitis obliterans and usual interstitial pneumonia represent separate and distinct clinicopathologic entities.

Entities:  

Mesh:

Year:  1986        PMID: 3717494     DOI: 10.1097/00000478-198606000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  20 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Clinicopathological study of migratory lung infiltrates.

Authors:  Y Miyagawa; N Nagata; N Shigematsu
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

4.  Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum.

Authors:  Carlyne D Cool; Steve D Groshong; Pradeep R Rai; Peter M Henson; J Scott Stewart; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2006-06-23       Impact factor: 21.405

5.  Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns.

Authors:  S Peyrol; J F Cordier; J A Grimaud
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

6.  Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans-organizing pneumonia.

Authors:  J L Myers; A L Katzenstein
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

Review 7.  Bronchiolitis obliterans with organising pneumonia: outcome.

Authors:  U Costabel; J Guzman; H Teschler
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

8.  Bronchiolitis obliterans-organizing pneumonia (BOOP) in children with malignant disease.

Authors:  K J Helton; J P Kuhn; B D Fletcher; J J Jenkins; D M Parham
Journal:  Pediatr Radiol       Date:  1992

9.  Comparison of clinicoradiologic manifestation of nonspecific interstitial pneumonia and usual interstitial pneumonia/idiopathic pulmonary fibrosis: a report from NRITLD.

Authors:  Saeid Fallah Tafti; Bahareh Mokri; Foroozan Mohammadi; Mehrdad Bakhshayesh-Karam; Habib Emami; Mohammad Reza Masjedi
Journal:  Ann Thorac Med       Date:  2008-10       Impact factor: 2.219

10.  Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.

Authors:  B Godeau; C Cormier; C J Menkes
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.